These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 33274007)
1. Protective Effect of miR-204 on Doxorubicin-Induced Cardiomyocyte Injury via HMGB1. Du Y; Liu G; Zhao L; Yao R Oxid Med Cell Longev; 2020; 2020():8819771. PubMed ID: 33274007 [TBL] [Abstract][Full Text] [Related]
2. Role of HMGB1 in doxorubicin-induced myocardial apoptosis and its regulation pathway. Yao Y; Xu X; Zhang G; Zhang Y; Qian W; Rui T Basic Res Cardiol; 2012 May; 107(3):267. PubMed ID: 22527657 [TBL] [Abstract][Full Text] [Related]
3. MiR-21 Protected Cardiomyocytes against Doxorubicin-Induced Apoptosis by Targeting BTG2. Tong Z; Jiang B; Wu Y; Liu Y; Li Y; Gao M; Jiang Y; Lv Q; Xiao X Int J Mol Sci; 2015 Jun; 16(7):14511-25. PubMed ID: 26132560 [TBL] [Abstract][Full Text] [Related]
4. Irigenin treatment alleviates doxorubicin (DOX)-induced cardiotoxicity by suppressing apoptosis, inflammation and oxidative stress via the increase of miR-425. Guo L; Zheng X; Wang E; Jia X; Wang G; Wen J Biomed Pharmacother; 2020 May; 125():109784. PubMed ID: 32092815 [TBL] [Abstract][Full Text] [Related]
5. MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte. Wan GX; Cheng L; Qin HL; Zhang YZ; Wang LY; Zhang YG Cardiovasc Toxicol; 2019 Jun; 19(3):264-275. PubMed ID: 30535663 [TBL] [Abstract][Full Text] [Related]
6. Circ_0001312 Silencing Suppresses Doxorubicin-Induced Cardiotoxicity via MiR-409-3p/HMGB1 Axis. Hu X; Liao W; Teng L; Ma R; Li H Int Heart J; 2023 Mar; 64(1):71-80. PubMed ID: 36725075 [TBL] [Abstract][Full Text] [Related]
7. Activation of Nrf2 by miR-152 Inhibits Doxorubicin-Induced Cardiotoxicity via Attenuation of Oxidative Stress, Inflammation, and Apoptosis. Zhang WB; Lai X; Guo XF Oxid Med Cell Longev; 2021; 2021():8860883. PubMed ID: 33574984 [TBL] [Abstract][Full Text] [Related]
8. miR-451 Silencing Inhibited Doxorubicin Exposure-Induced Cardiotoxicity in Mice. Li J; Wan W; Chen T; Tong S; Jiang X; Liu W Biomed Res Int; 2019; 2019():1528278. PubMed ID: 31355248 [TBL] [Abstract][Full Text] [Related]
10. MiR-129-5p protects against myocardial ischemia-reperfusion injury via targeting HMGB1. Chen ZX; He D; Mo QW; Xie LP; Liang JR; Liu L; Fu WJ Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4440-4450. PubMed ID: 32373982 [TBL] [Abstract][Full Text] [Related]
11. Dexrazoxane Protects Cardiomyocyte from Doxorubicin-Induced Apoptosis by Modulating miR-17-5p. Yu X; Ruan Y; Shen T; Qiu Q; Yan M; Sun S; Dou L; Huang X; Wang Q; Zhang X; Man Y; Tang W; Jin Z; Li J Biomed Res Int; 2020; 2020():5107193. PubMed ID: 32190669 [TBL] [Abstract][Full Text] [Related]
12. Glycyrrhizin improved autophagy flux via HMGB1-dependent Akt/mTOR signaling pathway to prevent Doxorubicin-induced cardiotoxicity. Lv X; Zhu Y; Deng Y; Zhang S; Zhang Q; Zhao B; Li G Toxicology; 2020 Aug; 441():152508. PubMed ID: 32525084 [TBL] [Abstract][Full Text] [Related]
13. C1qTNF-related protein-6 protects against doxorubicin-induced cardiac injury. Zheng WF; Zhang SY; Ma HF; Chang XW; Wang H J Cell Biochem; 2019 Jun; 120(6):10748-10755. PubMed ID: 30719766 [TBL] [Abstract][Full Text] [Related]
14. Short-term exercise training protects against doxorubicin-induced cardiac mitochondrial damage independent of HSP72. Kavazis AN; Smuder AJ; Min K; Tümer N; Powers SK Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1515-24. PubMed ID: 20833957 [TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA LINC00339 aggravates doxorubicin-induced cardiomyocyte apoptosis by targeting MiR-484. Li J; Li L; Li X; Wu S Biochem Biophys Res Commun; 2018 Sep; 503(4):3038-3043. PubMed ID: 30170730 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of miR-23a attenuates doxorubicin-induced mitochondria-dependent cardiomyocyte apoptosis by targeting the PGC-1α/Drp1 pathway. Du J; Hang P; Pan Y; Feng B; Zheng Y; Chen T; Zhao L; Du Z Toxicol Appl Pharmacol; 2019 Apr; 369():73-81. PubMed ID: 30831132 [TBL] [Abstract][Full Text] [Related]
17. MiR-24-3p Attenuates Doxorubicin-induced Cardiotoxicity via the Nrf2 Pathway in Mice. Fan D; Chen HB; Leng Y; Yang SJ Curr Med Sci; 2022 Feb; 42(1):48-55. PubMed ID: 35089495 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA miR-215-5p Regulates Doxorubicin-induced Cardiomyocyte Injury by Targeting ZEB2. Xiong X; He Q; Liu J; Dai R; Zhang H; Cao Z; Liao Y; Liu B; Zhou Y; Chen J; Chen M; Liu J J Cardiovasc Pharmacol; 2021 Oct; 78(4):622-629. PubMed ID: 34282068 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-29b Regulates the Mitochondria-Dependent Apoptotic Pathway by Targeting Bax in Doxorubicin Cardiotoxicity. Jing X; Yang J; Jiang L; Chen J; Wang H Cell Physiol Biochem; 2018; 48(2):692-704. PubMed ID: 30025410 [TBL] [Abstract][Full Text] [Related]
20. miR-21 suppression prevents cardiac alterations induced by d-galactose and doxorubicin. Bei Y; Wu X; Cretoiu D; Shi J; Zhou Q; Lin S; Wang H; Cheng Y; Zhang H; Xiao J; Li X J Mol Cell Cardiol; 2018 Feb; 115():130-141. PubMed ID: 29329959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]